DEPOSIT AGREEMENTDeposit Agreement • September 17th, 2021 • Exscientia LTD • Biological products, (no disgnostic substances) • New York
DEPOSIT AGREEMENT, dated as of [●], 2021, by and among (i) EXSCIENTIA PLC, a public limited company incorporated under the laws of England and Wales, and its successors (the “Company”), (ii) Citibank, N.A., a national banking association organized under the laws of the United States of America (“Citibank”) acting in its capacity as depositary, and any successor depositary hereunder (Citibank in such capacity, the “Depositary”), and (iii) all Holders and Beneficial Owners of American Depositary Shares issued hereunder (all such capitalized terms as hereinafter defined).
AMENDED AND RESTATED COLLABORATION AGREEMENT between Bayer AG Muellerstrasse 178 13353 Berlin Germany (hereinafter referred to as “BAYER”) and Exscientia Ltd. The Schrodinger Building Oxford Science Park Oxford, OX4 4GE United Kingdom (hereinafter...Exscientia LTD • September 17th, 2021 • Biological products, (no disgnostic substances)
Certain confidential information contained in this document, marked by [****], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.
ContractExscientia LTD • September 17th, 2021 • Biological products, (no disgnostic substances) • England and Wales
Certain information in this document, marked by brackets [****], has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as amended, because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • September 17th, 2021 • Exscientia LTD • Biological products, (no disgnostic substances) • New York
This Collaboration and License Agreement (the “Agreement”) is made and entered into as of 3 May, 2021 (the “Effective Date”) by and between Exscientia Limited, with its registered office at Level 3, Dundee One River Court, 5 West Victoria Dock Road, Dundee, United Kingdom (“Exscientia”), and Bristol-Myers Squibb Company, headquartered at 430 E. 29th Street, 14th Floor, New York, NY 10016 (“BMS”). Exscientia and BMS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
